Quantitative detection of plasma human immunodeficiency virus type 2 subtype A RNA by the NucliSens EasyQ assay (version 1.1)

Journal of Clinical Microbiology

Volumn 45, Issue 1, 2007, Pages 88-92

  Rodés, Berta ^a   Sheldon, Julie ^a   Toro, Carlos ^a   Cuevas, Laureano ^b   Pérez Pastrana, Esperanza ^b   Herrera, Inmaculada ^b   Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; ELECTRON MICROSCOPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SUPERNATANT; VIREMIA; VIRUS DETECTION; VIRUS LOAD;

HIV INFECTIONS; HIV-2; HUMANS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 33846224680     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01613-06     Document Type: Article

References (20)

1. + cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire. AIDS 17:S49-S54.
2. Ariyoshi, K., S. Jaffar, A. Alabi, N. Berry, M. Schim van der Loeff, S. Sabally, P. N'Gom, T. Corrah, R. Tedder, and H. Whittle. 2000. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. AIDS 14:339-344.
3. Berry, N., K. Ariyoshi, S. Jaffar, S. Sabally, T. Corrah, R. Tedder, and H. Whittle. 1998. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J. Hum. Virol. 1:457-468.
4. Bland, J., and D. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310.
5. Chen, Z., A. Luckay, D. L. Sodora, P. Telfer, P. Reed, A. Gettie, J. M. Kanu, R. F. Sadek, J. Yee, D. D. Ho, L. Zhang, and P. A. Marx. 1997. Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. J. Virol. 71:3953-3960.
6. Cilia, G., B. Rodes, E. Perez-Trallero, J. Arrizabalaga, and V. Soriano. 2001. Molecular evidence of homosexual transmission of HIV type 2 in Spain. AIDS Res. Hum. Retrovir. 17:417-422.
7. Damond, F., C. Apetrei, D. L. Robertson, S. Souquiere, A. Lepretre, S. Matheron, J. C. Plantier, F. Brun-Vezinet, and F. Simon. 2001. Variability of human immunodeficiency virus type 2 (HIV-2) infecting patients living in France. Virology 280:19-30.
8. Damond, F., M. Gueudin, S. Pueyo, I. Farfara, D. L. Robertson, D. Descamps, G. Chene, S. Matheron, P. Campa, F. Brun-Vezinet, and F. Simon. 2002. Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections. J. Clin. Microbiol. 40:3654-3659.
9. de Mendoza, C., M. Koppelman, B. Montes, V. Ferre, V. Soriano, H. Cuypers, M. Segondy, and T. Oosterlaken. 2005. Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma. J. Virol. Methods 127:54-59.
10. Gottlieb, G. S., S. E. Hawes, H. D. Agne, J. E. Stern, C. W. Critchlow, N. B. Kiviat, and P. S. Sow. 2006. Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission. AIDS 20:895-900.
11. Marlink, R., P. J. Kanki, I. Thior, K. Travers, G. Eisen, T. Siby, I. Traore, C. Hsieh, M. Dia, E. Gueye, J. Hellinger, A. Guèye-Ndiaye, J. Sankalé, I. Ndoye, S. Mboup, and M. E. Essex. 1994. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265:1587-1590.
12. Mullins, C., G. Eisen, S. Popper, A. Sarr, J. Sankalé, J. Berger, S. Wright, H. Chang, G. Coste, T. Cooley, P. Rice, P. Skolnik, M. Sullivan, and P. Kanki. 2004. Highly active antiretroviral therapy and viral response in HIV type 2 infection. Clin. Infect. Dis. 38:1771-1779.
13. Popper, S. J., A. D. Sarr, K. U. Travers, A. Gueye-Ndiaye, S. Mboup, M. E. Essex, and P. J. Kanki. 1999. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J. Infect. Dis. 180:1116-1121.
14. Rodes, B., J. Sheldon, C. Tore, V. Jimenez, M. A. Alvarez, and V. Soriano. 2006. Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy. J. Antimicrob. Chemother. 57:709-713.
15. Rodes, B., C. Toro, V. Jimenez, and V. Soriano. 2005. Viral response to antiretroviral therapy in a patient coinfected with HIV type 1 and type 2. Clin. Infect. Dis. 41:e19-e21.
16. Ruelle, J., B. K. Mukadi, M. Schutten, and P. Goubau. 2004. Quantitative real-time PCR on LightCycler for the detection of human immunodeficiency virus type 2 (HIV-2). J. Virol. Methods 117:67-74.
17. Schim van der Loeff, M. F., A. Hansmann, A. A. Awasana, M. O. Ota, D. O'Donovan, R. Sarge-Njie, K. Ariyoshi, P. Milligan, and H. Whittle. 2003. Survival of HIV-1 and HIV-2 perinatally infected children in The Gambia. AIDS 17:2389-2394.
18. Soriano, V., P. Gomes, W. Heneine, A. Holguin, M. Doruana, R. Antunes, K. Mansinho, W. M. Switzer, C. Araujo, V. Shanmugam, H. Lourenco, J. Gonzalez-Lahoz, and F. Antunes. 2000. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J. Med. Virol. 61:111-116.
19. Van Beuningen, R., S. A. Marras, F. R. Kramer, T. Oosterlaken, J. Westeun, G. Borst, and P. A. van de Wiel. 2001. Development of a high throughput detection system for HIV-1 using real-time NASBA based on molecular beacons, p. 66-72. In R. Raghvachari and W. Tan (ed.), Genomics and proteomics technologies, proceedings of SPIE, vol. 4264. Society of Photot-Optical Instrumentation Engineers, Washington, DC.
20. Vandamme, A., M. Witvrouw, C. Pannecouque, J. Balzarini, K. Van Laethem, J. Schmit, J. Desmyter, and E. De Clerq. 2000. Evaluating clinical isolates for their phenotypic and genotypic resistance against anti-HIV drugs, p. 231. In R. Schinazi (ed.), Antiviral methods and protocols. Humana Press, Totowa, NJ.